Compare HNI & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HNI | HCM |
|---|---|---|
| Founded | 1944 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | 1796 |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 1994 | N/A |
| Metric | HNI | HCM |
|---|---|---|
| Price | $34.85 | $10.25 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $70.00 | $13.75 |
| AVG Volume (30 Days) | ★ 662.7K | 60.0K |
| Earning Date | 05-06-2026 | 03-05-2026 |
| Dividend Yield | ★ 3.73% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,839,000,000.00 | N/A |
| Revenue This Year | $117.19 | $20.60 |
| Revenue Next Year | $3.68 | $15.62 |
| P/E Ratio | ★ N/A | $5.49 |
| Revenue Growth | ★ 12.37 | N/A |
| 52 Week Low | $28.93 | $10.01 |
| 52 Week High | $53.29 | $19.50 |
| Indicator | HNI | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 62.46 | 28.20 |
| Support Level | $33.72 | N/A |
| Resistance Level | $47.41 | $15.75 |
| Average True Range (ATR) | 1.45 | 0.29 |
| MACD | 0.47 | 0.00 |
| Stochastic Oscillator | 93.01 | 15.70 |
HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.